# FDA recall D-0660-2024

> **Glenmark Pharmaceuticals Inc., USA** · Class II · drug recall initiated 2024-08-30.

## Product

Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, 07430, NDC 68462-180-22.

## Reason for recall

Subpotent Drug

## Distribution

Product was distributed nationwide within the United States.

## Key facts

- **Recall number:** D-0660-2024
- **Recalling firm:** Glenmark Pharmaceuticals Inc., USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Completed
- **Initiation date:** 2024-08-30
- **Report date:** 2024-10-02

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Mahwah, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0660-2024

## Citation

> AI Analytics. FDA recall D-0660-2024. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0660-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*